| New CRISPR Startup from Feng Zhang Revealed | Corie Lok | 04/27/18 | Boston |
| Home Tests in Mind, Doudna Startup Races Rivals in CRISPR Diagnostics | Alex Lash | 04/26/18 | San Francisco |
| Bio Roundup: Ex-Kiters Say Allo, NASH Cash & Data, Alkermes No & More | Alex Lash | 04/06/18 | National |
| Bio Roundup: DIY Biohacking, PCSK9 Data, Solid Setback & More | Frank Vinluan | 03/16/18 | National |
| No Self-Editing: Biohacker Josiah Zayner Can’t Stop Living Out Loud | Alex Lash | 03/13/18 | San Francisco |
| Paying for Gene Therapy, CRISPR in People, RNAi at “What’s Hot” on May 16 | Ben Fidler | 03/05/18 | Boston |
| Continuing Cell Therapy Push, Gilead Aligns with Sangamo for CAR-T Boost | Ben Fidler | 02/22/18 | San Francisco |
| Bio Roundup: Spark’s Road Ahead, Juno Rumors, Merck’s Big Day & More | Ben Fidler | 01/19/18 | National |
| CRISPR Recovery? “Furor” Briefly Snips $500M From Companies’ Values | Alex Lash | 01/12/18 | Boston |
| Gene Therapy 2.0: New Startups Aim to Fine-Tune Gene Delivery and Control | Ben Fidler | 01/04/18 | Boston |
| Promega, Cellectar, Blockchain, & More: This Week’s WI Watchlist | Jeff Buchanan | 12/08/17 | Wisconsin |
| Bio Roundup: Trials to Watch, Mega Deals, Video Game Therapy & More | Ben Fidler | 12/08/17 | Boston |
| 15 For ’18: Key Clinical Data to Watch For Next Year (Part 2) | Alex Lash | 12/06/17 | National |
| Locus Bio Raises $19M for CRISPR-Cas3 Antimicrobial “Smart Bombs” | Frank Vinluan | 11/14/17 | Raleigh Durham |
| With $40M for Exonics, Duchenne’s Gene Therapy, CRISPR Race Heats Up | Ben Fidler | 11/08/17 | Boston |
| Bio Roundup: Kite’s CAR-T Approved, Obamacare Fix & Lilly mRNA Deal | Frank Vinluan | 10/20/17 | National |
| CRISPR Therapeutics Switches CEOs As It Approaches First Clinical Study | Alex Lash | 10/02/17 | Boston |
| KSQ Bets on CRISPR-Juiced Drug Discovery With $76M & Ex-Genzyme CEO | Ben Fidler | 10/02/17 | Boston |
| Bio Roundup: RNAi’s Big Day, CAR-T For Kids, Drugs From Fungi & More | Ben Fidler | 09/22/17 | National |
| Alnylam Data Puts a Nobel Discovery One Step Closer to Approved Drug | Ben Fidler | 09/20/17 | Boston |
| As Key Data Loom, Nobel Winner Mello Reflects on RNAi “Sci-Fi” Story | Ben Fidler | 09/06/17 | Boston |
| Startup Builders, IPO Closers & More: Meet Xconomy’s CEO Award Finalists | Ben Fidler | 08/10/17 | Boston |
| Bio Roundup: CRISPR Advances, Obamacare Lives, FDA Nods & More | Ben Fidler | 08/04/17 | National |
| Homology Med Bags $83.5M More, Fueling Push For Gene Editing Twist | Ben Fidler | 08/01/17 | Boston |
| CRISPR Pioneer Zhang Preaches Extra Caution In Human Gene Editing | Alex Lash | 07/31/17 | Boston |
| Bio Roundup: GOP Drama, Immunotherapy Setbacks, Pharma Revamps | Ben Fidler | 07/28/17 | National |
| Boston Is Arguably the Heart of Biotech. But Who Makes It So? Have Your Say. | Ben Fidler | 06/26/17 | Boston |
| Bio Roundup: Senate Trumpcare, FDA On Cancer, Alzheimer Review & More | Alex Lash | 06/23/17 | National |
| Unconventional Partners, Like FDA, Can Drive Adoption of New Tech | James Coon | 05/24/17 | Boston |
| Bio Roundup: CRISPR Appeal, Bristol Deals, Stock Pumping & More | Ben Fidler | 04/14/17 | National |
